Inflammatory hypertrophic cauda equina syndrome following intrathecal neural stem cell injection
Conclusions: Safety of intrathecal stem cell treatments is not routinely regulated in commercial overseas stem cell facilities. We wish to bring this potential complication to the attention of health care providers. Muscle Nerve, 2013
Source: Muscle and Nerve - Category: Internal Medicine Authors: Richard W. Hurst, E. Peter Bosch, Jonathan M. Morris, P. James B. Dyck, Ronald K. Reeves Tags: Case of the Month Source Type: research
More News: Chronic Pain | Depression | Health Management | Internal Medicine | Osteoarthritis | Pain | Stem Cell Therapy | Stem Cells | Stroke | Study